Katey Einterz Owen
Director · Adaptive Biotechnologies Corp
IndividualSelling only
- 2026
- Sep 2, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Katey Einterz Owen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M in ADPT purchases and sales in the last 12 months
- Harlan S. Robins - $29.48M in ADPT purchases and sales in the last 12 months
- Julie Rubinstein - $16.25M in ADPT purchases and sales in the last 12 months
- Sharon Benzeno - $14.48M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Kyle Piskel - $3.58M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Katey Einterz Owen?
Katey Einterz Owen is a corporate insider, tracked as Director of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Katey Einterz Owen submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Katey Einterz Owen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($250K) across all tracked filings.
